ReViral Ltd

ReViral Ltd

ReViral Ltd

ReViral is a UKbased biotechnology company developing firstinclass drugs to treat RSV infections.
Type
B2c
Founded
2011
Raised
$99M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Team Size
1–10
Employees
$44,000,000 Venture capital (Series C)
FinSMEs

ReViral Raises $44M in Series C Financing

PE HUB

VC-backed ReViral taps Musso as CFO

$55,000,000 Venture capital (Series B)
MedCity News , FinSMEs , PE HUB

ReViral closes $55 million Series B funding round for RSV drug